Discontinued — last reported Q1 '23
Geographic · Operating Loss Carryforwards
Other Jurisdictions — Operating Loss Carryforwards
Analysis
StatementSegment
CategoryRisk
SignalHigher is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ1 2023
Rolls up toNet Operating Loss Carryforwards
How to read this metric
An increase indicates that the company has accumulated significant tax-deductible losses, which may provide future tax benefits if the international segments become profitable. A decrease suggests that the company is either utilizing these losses to offset taxable income or that the tax assets have expired.
Detailed definition
This metric represents the cumulative tax-deductible operating losses generated by the company's business units operatin...
Peer comparison
Similar to deferred tax assets or net operating loss (NOL) carryforwards reported by other multinational biopharmaceutical or holding companies, though specific regional tax laws vary significantly.
Metric ID:
roiv_segment_other_jurisdictions_operating_loss_carryforwardsHistorical Data
1 periods
| Q1 '23 | |
|---|---|
| Value | $67.70M |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's other jurisdictions — operating loss carryforwards?
- Roivant Sciences (ROIV) reported other jurisdictions — operating loss carryforwards of $67.70M in Q1 2023.
- What does other jurisdictions — operating loss carryforwards mean?
- The total amount of past operating losses in international regions that can be used to lower future tax payments in those same regions.